Terns Pharmaceuticals (TERN) Competitors $2.99 -0.16 (-5.08%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.03 +0.04 (+1.20%) As of 05/21/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TERN vs. WVE, GYRE, PAHC, MLYS, COLL, SNDX, RCUS, ELVN, AVDL, and SYREShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Wave Life Sciences (WVE), Gyre Therapeutics (GYRE), Phibro Animal Health (PAHC), Mineralys Therapeutics (MLYS), Collegium Pharmaceutical (COLL), Syndax Pharmaceuticals (SNDX), Arcus Biosciences (RCUS), Enliven Therapeutics (ELVN), Avadel Pharmaceuticals (AVDL), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Terns Pharmaceuticals vs. Wave Life Sciences Gyre Therapeutics Phibro Animal Health Mineralys Therapeutics Collegium Pharmaceutical Syndax Pharmaceuticals Arcus Biosciences Enliven Therapeutics Avadel Pharmaceuticals Spyre Therapeutics Terns Pharmaceuticals (NASDAQ:TERN) and Wave Life Sciences (NASDAQ:WVE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations. Which has stronger earnings & valuation, TERN or WVE? Wave Life Sciences has higher revenue and earnings than Terns Pharmaceuticals. Wave Life Sciences is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns PharmaceuticalsN/AN/A-$90.21M-$1.09-2.74Wave Life Sciences$104.94M8.87-$57.51M-$0.84-7.19 Do insiders & institutionals believe in TERN or WVE? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. Comparatively, 89.7% of Wave Life Sciences shares are held by institutional investors. 1.5% of Terns Pharmaceuticals shares are held by company insiders. Comparatively, 29.1% of Wave Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is TERN or WVE more profitable? Terns Pharmaceuticals has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Terns Pharmaceuticals' return on equity of -32.76% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -32.76% -31.33% Wave Life Sciences -66.50%-280.57%-52.90% Does the MarketBeat Community favor TERN or WVE? Wave Life Sciences received 324 more outperform votes than Terns Pharmaceuticals when rated by MarketBeat users. Likewise, 67.77% of users gave Wave Life Sciences an outperform vote while only 60.27% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTerns PharmaceuticalsOutperform Votes4460.27% Underperform Votes2939.73% Wave Life SciencesOutperform Votes36867.77% Underperform Votes17532.23% Does the media favor TERN or WVE? In the previous week, Wave Life Sciences had 7 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 12 mentions for Wave Life Sciences and 5 mentions for Terns Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 1.34 beat Wave Life Sciences' score of 1.15 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Wave Life Sciences 9 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TERN or WVE? Terns Pharmaceuticals presently has a consensus price target of $15.63, indicating a potential upside of 422.58%. Wave Life Sciences has a consensus price target of $21.17, indicating a potential upside of 250.44%. Given Terns Pharmaceuticals' higher probable upside, equities analysts plainly believe Terns Pharmaceuticals is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility & risk, TERN or WVE? Terns Pharmaceuticals has a beta of -0.16, meaning that its stock price is 116% less volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -0.92, meaning that its stock price is 192% less volatile than the S&P 500. SummaryWave Life Sciences beats Terns Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$261.14M$6.52B$5.37B$8.39BDividend YieldN/A2.65%5.22%4.10%P/E Ratio-2.538.9226.8419.71Price / SalesN/A253.80392.34117.39Price / CashN/A65.8538.2534.62Price / Book0.726.466.794.50Net Income-$90.21M$143.98M$3.23B$248.18M7 Day Performance7.17%2.03%1.53%0.20%1 Month Performance6.79%4.11%10.05%12.37%1 Year Performance-49.58%-2.87%16.71%7.04% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.0956 of 5 stars$2.99-5.1%$15.63+422.6%-51.1%$261.14MN/A-2.5340News CoveragePositive NewsGap DownWVEWave Life Sciences4.367 of 5 stars$6.60+0.2%$21.17+220.7%-4.4%$1.02B$108.30M-5.95240Positive NewsGap DownGYREGyre Therapeutics0.281 of 5 stars$10.83+13.6%N/A-20.8%$1.02B$105.76M541.5040PAHCPhibro Animal Health3.5339 of 5 stars$24.50+9.0%$20.00-18.4%+26.6%$992.32M$1.11B51.041,860Positive NewsMLYSMineralys Therapeutics2.7534 of 5 stars$15.01+2.5%$33.00+119.9%+29.0%$973.79MN/A-4.1228Gap DownCOLLCollegium Pharmaceutical4.0618 of 5 stars$29.56+2.3%$43.80+48.2%-14.6%$949.82M$631.45M12.74210Gap UpSNDXSyndax Pharmaceuticals3.8354 of 5 stars$10.99+2.7%$35.91+226.7%-48.5%$945.66M$43.72M-3.03110Positive NewsRCUSArcus Biosciences3.5472 of 5 stars$8.82+6.5%$25.67+191.2%-49.9%$933.38M$141M-2.80500Gap UpHigh Trading VolumeELVNEnliven Therapeutics2.4856 of 5 stars$19.01+3.2%$40.33+112.2%-26.1%$932.75MN/A-10.0150Analyst RevisionGap UpAVDLAvadel Pharmaceuticals2.2304 of 5 stars$9.59+2.1%$19.43+102.6%-42.8%$926.67M$169.12M-12.1470Positive NewsSYRESpyre Therapeutics2.3341 of 5 stars$14.93+5.9%$51.17+242.7%-59.0%$899.92M$890,000.00-2.00100Positive NewsGap Down Related Companies and Tools Related Companies Wave Life Sciences Competitors Gyre Therapeutics Competitors Phibro Animal Health Competitors Mineralys Therapeutics Competitors Collegium Pharmaceutical Competitors Syndax Pharmaceuticals Competitors Arcus Biosciences Competitors Enliven Therapeutics Competitors Avadel Pharmaceuticals Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TERN) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TERN Stock Free TERN Stock Alerts